Acta Dermato-Venereologica 97-6 97-6CompleteContent | Page 33
17 th ESDaP Congress on June 21–23, 2017 in Brest, France. www.isa2017.com
7 European Post-Chicago Melanoma/Skin Cancer Meeting:
Results and Interpretations of ASCO Presentations 2017: In-
terdisciplinary Global Conference on News in Melanoma/Skin
Cancer on June 29–30, 2017 in Munich, Germany. Inf: http://
www.melanomaglobal2017.org. 31 st IUSTI-Europe Congress on Sexually Transmitted Infections
on August 31–September 2, 2017 in Helsinki, Finland. Inf:
www.iusti2017.org.
97 th Annual Meeting of the British Association of Dermato-
logists on July 4–6, 2017 in Liverpool, UK. Inf: http://www.
bad.org.uk/events 9 th World Congress of Melanoma on October 18–21, 2017 in
Brisbane, Australia. Inf: www.worldmelanoma2017.com.
th
5 th International Summer Academy of Practical Dermatology
(ISA 2017) on July 25–29, 2017 in Munich, Germany. Inf:
ANNOUNCEMENT
9 th World Congress on Itch on October 15–17, 2017 in Wroclaw,
Poland.
24 th World Congress of Dermatology on June 10–15, 2019 in
Milan, Italy. Inf: www.wcd2019milan.org/.
BOOK REVIEW
Therapy for Severe Psoriasis, 1 st Edition, by Jashin
Wu, Steven R. Feldman and Mark G. Lebwohl, 216
pages. ISBN: 9780323447973. Hardcover. Price:
£58.49. Elsevier Health Sciences, 2017.
The book includes 16 chapters, the first chapter gives a
well written short overview of psoriasis, epidemiology,
cause and pathogenesis, subtypes and local treatments.
Next are chapters on ultraviolet treatment (UVB and
PUVA), systemically treatments, biological treatments,
combination and new upcoming treatments. All authors
are from US, which is reflected by the reference to FDA
approvals and recommendations.
The aim of the book is to give a practical guide in
treating patients with severe psoriasis, and as a reference
book. The book gives a fine overview of the treatments
available for patients with moderate to severe psoriasis.
Each chapter is written as an independent section and
the editors must have thought that the reader will read
single chapters or use the book as a reference book.
However, if you read more chapters consecutively or the
entire book then there is a lot of repetition. An example
is the case of re-UVB or re-PUVA which is discussed
Acta Derm Venereol 2017; 97: 772
in both the chapters with ultraviolet treatment and the
chapter with acitretin. Another example is that in nearly
all chapters with biological treatment the monitoring for
tuberculosis and precautions in case of vaccinations is
repeated. A suggestion for the next edition could be to
collect the chapter on all anti-TNF biologicals and more
focus on the effect and differences of the individual
drugs. The book is thought as a practical book and a
lot of suggestions on how to start and control the treat-
ments are included. However for the old and well known
drugs, more information could be included. For example
about the need to control for skeletal calcification during
acitretin treatment and about how to use liver test such
as procollagen III peptide and fibroscan in monitoring
methotrexate therapy.
In the end of each chapter is a short summary including
which patients will benefit from the treatment, and im-
portant information about the treatment; this works well.
An optional way to expand on this part could be a chapter
on how to select treatment for the individual patient.
Lone Skov
Section Editor
doi: 10.2340/00015555-2696
www.medicaljournals.se/acta
Journal Compilation © 2017 Acta Dermato-Venereologica.